Clinical and pathogenic features of SCCmec type II and IV methicillin-resistant Staphylococcus aureus in Japan

Area of Science:

• Microbiology
• Infectious Diseases
• Genetics

Background:

• Staphylococcal chromosomal cassette mec (SCCmec) type IV methicillin-resistant Staphylococcus aureus (MRSA) is prevalent globally, but its characteristics in Japan remain underexplored.
• Japanese SCCmec type IV MRSA clones exhibit distinct genetic profiles compared to those in the US and Europe.

Purpose of the Study:

• To compare the clinical and genetic characteristics of SCCmec type II and type IV MRSA in Japan.
• To elucidate the differences between these two prevalent MRSA types in a Japanese patient population.

Main Methods:

• Retrospective analysis of 55 SCCmec type II and 101 type IV MRSA samples from lower respiratory tract, skin, or soft tissue infections.
• Comparison of patient demographics, infection types, and distribution of key MRSA pathogenic genes (sea, seb, sem, seo).

Main Results:

• Patients with SCCmec type IV MRSA were significantly younger than those with type II (P < 0.001).
• SCCmec type IV MRSA was associated with a lower rate of pneumonia (7.8% vs 29.0%, P = 0.026), while skin and soft tissue infection rates were similar (66.0% vs 61.9%, P = 0.788).
• Significant differences in pathogenic gene distribution (P < 0.001) suggest distinct clonal complexes for SCCmec types II and IV.

Conclusions:

• Japanese SCCmec type II and IV MRSA strains possess distinct epidemiological and genetic features.
• Understanding these differences is crucial for effective management and treatment strategies for MRSA infections in Japan.